Sep 14, 2020
Sheila Gujrathi, MD and Larry Zisman, MD of Gossamer Bio discuss the
development of an investigational new treatment for pulmonary
arterial hypertension and their Phase 2 Clinical Trial for
GB0002.
Learn more about their Clinical Study of Inhaled GB002 for
Treatment of WHO Group I Pulmonary Arterial Hypertension (PAH):
https://clinicaltrials.gov/ct2/show/NCT03926793
Learn more about pulmonary hypertension trials at www.phaware.global/clinicaltrials. Never miss an episode with the phaware® podcast app. Follow us @phaware on Facebook, Twitter, Instagram, YouTube & Linkedin Engage for a cure: www.phaware.global/donate #phawareMD #ClinicalTrials @GossamerBio